Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 2/20 | 0.32 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10039375 | 0.92 | ALDH1A1 (0.47) | PDK2ALDH1A1PTPRCMAOAMAOB | |
| SCHEMBL16346844 | 0.90 | ALDH1A1 (0.41) | PDK2ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL16346749 | 0.90 | ALDH1A1 (0.41) | PDK2ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL5846694 | 0.90 | ALDH1A1 (0.41) | PDK2ALDH1A1TDP1KDM4EMAPT | |
| SCHEMBL2395101 | 0.88 | PDK2 (0.41) | PDK2ALDH1A1PTPRC | |
| SCHEMBL21174567 | 0.85 | MEN1 (0.41) | PDK2ALDH1A1PTPRCOPRM1OPRD1 | |
| SCHEMBL30082735 | 0.85 | MEN1 (0.41) | PDK2ALDH1A1PTPRCOPRM1OPRD1 | |
| SCHEMBL783450 | 0.85 | PDK2 (0.58) | PDK2ALDH1A1PTPRCOPRM1OPRD1 | |
| SCHEMBL29574412 | 0.85 | PDK2 (0.58) | PDK2ALDH1A1PTPRCOPRM1OPRD1 | |
| SCHEMBL996751 | 0.85 | PDK2 (0.58) | PDK2ALDH1A1PTPRCOPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2371813-A1 | Spirobifluorene-based compound and dye-sensitized solar cell using the same | Samsung SDI Co., Ltd. (KR) | 2011-10-05 | — | — | EP | disclosed |
| EP-2371813-A1 | Spirobifluorene-based compound and dye-sensitized solar cell using the same | Samsung SDI Co., Ltd. (KR) | 2011-10-05 | — | — | EP | disclosed |
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
| WO-2007086701-A1 | ELECTROLUMINESCENT COMPOUNDS COMPRISING FLUORENE GROUP AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110232763-A1 | SPIROBIFLUORENE-BASED COMPOUND AND DYE-SENSITIZED SOLAR CELL USING THE SAME | TRPA1, FDFT1, STOM | PDK2 283/4885ALDH1A1 384/4885PTPRC 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.